List of works - Irena Frydecka

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation

scientific article published on 5 May 2015

Alterations in both the activatory and inhibitory potential of peripheral blood CD4+ T cells in rheumatoid arthritis patients correlate with disease progression

scientific article published on 10 September 2013

Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases

scientific article

Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population

article

Blood serum levels of soluble forms of adhesion molecules ICAM-1 (sICAM-1) and selectin E (s-selectin E) in patients with various phases of non-Hodgkin's lymphomas.

scientific article

Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia

scientific article published on 01 October 2004

CD28 costimulatory molecule--expression, structure and function.

scientific article

CD28 downregulation on CD4+ T cells is associated with age of kidney transplant recipient

scientific article

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease

scientific article published on 16 September 2016

CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course

CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region

article

CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia

scientific article published on 24 May 2015

CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.

scientific article

Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

scientific article published on 9 May 2011

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.

scientific article published in November 2002

Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production

scientific article

Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis

scientific article

Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression

scientific article

Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.

scientific article published on 27 February 2017

Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors

scientific article

Gene polymorphisms of novel immunotolerant molecule BTLA: distribution of alleles, genotypes and haplotypes in Polish Caucasian population

scientific article

High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease

scientific article published on 06 January 2009

ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population

scientific article published on 01 January 2011

Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.

scientific article

Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population

article

Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia

scientific article published on 08 December 2016

Is cyclin D2 a marker of B-cLL cell activation?

scientific article published on 01 January 2009

Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region

article

PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.

scientific article published on 9 February 2017

PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease

scientific article published on 21 April 2013

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody

scientific article published on 21 October 2015

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement

scientific article

Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.

scientific article published on April 2015

Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.

scientific article published in October 2002

Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms

scientific article published on 4 September 2009

The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease

scientific article published on 17 February 2009

The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

scientific article published on 7 February 2018

The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia

scientific article

The significance of Treg cells in defective tumor immunity

scientific article published on 30 May 2008

The soluble CTLA-4 receptor: a new marker in autoimmune diseases.

scientific article

Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population

scientific article published on 9 July 2011

[Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results]

scientific article published on 01 January 2006

[Fas receptor expression on peripheral blood T lymphocytes in patients with secondary progressive multiple sclerosis]

scientific article published on 01 May 2003

[Intravenous immunoglobulin preparations for treatment of lymphoreticular malignancies in adults]

scientific article published on 01 January 2002

[Structure and function of lymphocyte TCR/CD3 complex]

scientific article published on 01 January 2003

[Variable expression of CD28 costimulatory molecule and CTLA4 inhibitory molecule on peripheral blood CD4+ cells in kidney allograft recipients with and without acute graft rejection]

scientific article published on 01 August 2006

rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?

scientific article published on 14 May 2013

List of works by Irena Frydecka

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation

Alterations in both the activatory and inhibitory potential of peripheral blood CD4+ T cells in rheumatoid arthritis patients correlate with disease progression

Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases

Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population

Blood serum levels of soluble forms of adhesion molecules ICAM-1 (sICAM-1) and selectin E (s-selectin E) in patients with various phases of non-Hodgkin's lymphomas.

Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia

CD28 costimulatory molecule--expression, structure and function.

CD28 downregulation on CD4+ T cells is associated with age of kidney transplant recipient

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease

CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course

CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region

CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia

CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.

Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.

Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production

Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis

Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression

Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.

Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors

Gene polymorphisms of novel immunotolerant molecule BTLA: distribution of alleles, genotypes and haplotypes in Polish Caucasian population

High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease

ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population

Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.

Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population

Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia

Is cyclin D2 a marker of B-cLL cell activation?

Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region

PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.

PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement

Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.

Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.

Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms

The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease

The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia

The significance of Treg cells in defective tumor immunity

The soluble CTLA-4 receptor: a new marker in autoimmune diseases.

Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population

[Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results]

[Fas receptor expression on peripheral blood T lymphocytes in patients with secondary progressive multiple sclerosis]

[Intravenous immunoglobulin preparations for treatment of lymphoreticular malignancies in adults]

[Structure and function of lymphocyte TCR/CD3 complex]

[Variable expression of CD28 costimulatory molecule and CTLA4 inhibitory molecule on peripheral blood CD4+ cells in kidney allograft recipients with and without acute graft rejection]

rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?